3 Firms Face Off For Lead Counsel Spot In Blood Drug Suit
It's a battle of law firm resumes as three firms vie for the lead counsel spot to represent investors in a securities class action against an Israeli biotech firm that is...To view the full article, register now.
Already a subscriber? Click here to view full article